One interesting finding in our present study is that the enhancement of reciprocal Mav CFA-specific Th1/Th17 CD4+ T cell responses substantially contributed to the prevention of disease progression after Mav SMC #7 infection, but these cells had an almost negligible adjunctive therapeutic effect when applied in combination with antibiotic treatment. The gene discussed is CD4; the disease is infection.